XT
CGTX icon

XTX Topco’s Cognition Therapeutics CGTX Stock Holding History

XTX Topco’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149K Buy
195,803
+158,576
+426% +$185K ﹤0.01% 2958
2025
Q4 		$50.3K Buy
+37,227
New +$60.4K ﹤0.01% 2833
2025
Q3 		– Sell
-16,603
Closed -$5.14K – 2645
2025
Q2 		$5.14K Buy
+16,603
New +$5.61K ﹤0.01% 2256

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

XTX Topco's CGTX Position: Q1 2026 in Review

XTX Topco increased its Cognition Therapeutics (CGTX) stake by 426% in Q1 2026, buying an estimated $185K and bringing the position to 195,803 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #2958.

XTX Topco first reported a position in CGTX in Q2 2025 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • XTX Topco held 195,803 shares of Cognition Therapeutics worth $149K as of Q1 2026.
  • XTX Topco bought 158,576 Cognition Therapeutics shares in Q1 2026, an estimated $185K.
  • Cognition Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2958 holding.
  • XTX Topco first reported a position in Cognition Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.